From new strategies for prevention to innovative treatments and revealing insights into the pathogenesis of human immunodeficiency virus (HIV), investigators in the Division of Infectious Disease are making significant strides in AIDS research. Mount Sinai ranked fourteenth in the country for AIDS work in US News and World Reports' 2006 Best Graduate School Issue.
While unquestionably a leader in AIDS research, research in the division spans many areas. The division is home to the Emerging Pathogens Center, HIV-Associated Nephropathy Program, HIV Clinical Trials, Microbicide Development Program, and Transplantation Infectious Diseases Program.
In addition to these programs other major areas of research include studies of individuals co-infected with HIV and hepatitis C, innate viral immunity, the interplay between HIV-1 and innate intracellular defenses, the host-pathogen interactions with the intracellular pathogens, salmonella and francisella and the epidemiology of hospital-acquired infections and emerging pathogens.
Many of the division's projects are multi-disciplinary with colleagues from Mount Sinai's Department of Microbiology, the Recanati Miller Transplantation Institute, Department of Pediatrics, the Department of Medicine's Division of Nephrology and Liver Medicine and others throughout Icahn School of Medicine.
The Division has an NIH training grant to support physician scientists seeking advanced training in viral pathogenesis and participates in additional training grants for students and post-doctoral candidates interested in participating in the ongoing research projects within the division.